money found for our users $0 and counting. see how it works
claimscout

Depo-Provera Brain Tumor (Meningioma)

In litigation Mass-tort payouts ($50k+) mass_tort · pharma

Depo-Provera brain tumor (meningioma) - MDL 3140 consolidated in N.D. Florida, litigation ramping

Eligibility hint
Received two or more Depo-Provera birth-control injections and were later diagnosed with a meningioma or other brain tumor
Estimated payout range
$50,000 – $1,500,000
Current score
0.80 / 1.00
Official source
Pfizer faces a fast-growing wave of lawsuits alleging its injectable contraceptive Depo-Provera (medroxyprogesterone acetate) causes intracranial meningioma, a brain tumor. A 2024 BMJ study found prolonged use was associated with a materially elevated meningioma risk, and plaintiffs allege Pfizer failed to warn US users despite carrying such warnings abroad. The federal cases were consolidated in February 2025 as MDL No. 3140 in the Northern District of Florida before Judge M. Casey Rodgers; bellwether selection and discovery are underway and no settlement exists yet. Eligibility centers on repeated Depo-Provera use and a meningioma diagnosis.

Connected settlement administrations (1)

Recent signals

Brands: pfizerpharmacia & upjohngreenstone
Products: depo-proveradepo proveramedroxyprogesteronemedroxyprogesterone acetatebirth control shotcontraceptive injection

Frequently asked questions

Who qualifies for the Depo-Provera Brain Tumor (Meningioma) case?

You may qualify if the following applies to you: Received two or more Depo-Provera birth-control injections and were later diagnosed with a meningioma or other brain tumor. Eligibility criteria can change as the case develops.

How much could a Depo-Provera Brain Tumor (Meningioma) claim be worth?

Estimated payouts range from $50,000 to $1,500,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.

What is the current status of the Depo-Provera Brain Tumor (Meningioma) case?

In litigation. Pfizer faces a fast-growing wave of lawsuits alleging its injectable contraceptive Depo-Provera (medroxyprogesterone acetate) causes intracranial meningioma, a brain tumor. A 2024 BMJ study found prolonged use was associated with a materially elevated meningioma risk, and plaintiffs allege Pfizer failed to warn US users despite carrying such warnings abroad. The federal cases were consolidated in February 2025 as MDL No. 3140 in the Northern District of Florida before Judge M. Casey Rodgers; bellwether selection and discovery are underway and no settlement exists yet. Eligibility centers on repeated Depo-Provera use and a meningioma diagnosis.

How do I check whether I'm included?

Take the free 30-second audit at https://www.getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://www.getclaimscout.com/matters/depo-provera.

Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.

Start audit →
Get a heads up when you're owed money We email you the moment a new settlement or claim opens that could fit you. Free, no spam.
Class action settlements pay out via:
🏦Bank transfer
Paper check
PayPal
Venmo
Zelle
💳Prepaid card
Apple Pay
Google Pay
The method is set by the administrator for each settlement, not by claimscout. We never touch the money.